Skip to content

Ambu Aura GainTM Guided vs Non Guided in Edentulous Ambu Aura GainTM Without Gastric Tube in Endontolous Patient

Comparison of the Ambu Aura GainTM With Gastric Tube Versus the Ambu Aura GainTM Without Gastric Tube in Endontolous Patient

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03933644
Enrollment
70
Registered
2019-05-01
Start date
2019-05-15
Completion date
2020-02-12
Last updated
2020-11-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oropharyngeal Leak Pressure

Brief summary

The Ambu® Aura GainTM is a relatively new 2nd generation Supraglottic Airway Device (SGA) with a second port, providing gastric access to drain gastric content and air and it has an intergrated bite-block that helps avoiding rotation of the SGA. It has been described and it is known from daily routine, that SGA in edentulous patient provide inferior oropharyngeal leak pressure (OLP). The aim of the study is to evaluate if the placement of a gastric tube through the second orifice leads to better OLP and lowers the number of intervention needed for replacing the SGA. The study also evaluates the OLP after 15 minutes and after 30 minutes.

Interventions

SGA is inserted with a gastric tube as guide for insertion

DEVICENo gastric Tube

SGA is inserted without a gastric tube as guide for insertion

Sponsors

Medical University Innsbruck
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* ASA I - 3 * Signed informed consent * Age 18 - 90 years * Edentolous (or partial) patients * Patients scheduled for elective surgery

Exclusion criteria

* Patients with a known or predicted difficult airway * Patients with anatomical disorders in the upper airway, the oesophagus or the trachea * Patients at risk for aspiration * Body mass index (BMI) \> 40 kg/m2

Design outcomes

Primary

MeasureTime frameDescription
Oropharyngeal Leak Pressureimmediately after insertionafter insertion

Secondary

MeasureTime frameDescription
Oropharyngeal Leak Pressure15 minutesafter 15 minutes

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026